Atlas Biomed's Visionary Approach to Personalized Health: An Overview of their Series B Pitch Deck
About Atlas Biomed
Atlas Biomed, a groundbreaking startup, is transforming the health industry through its DNA and microbiome tests. These personalized tests aim to empower individuals by furnishing detailed reports on various health aspects, such as hereditary diseases, carrier status, nutrients, and vitamins. The company also provides personalized food recommendations based on their diagnostics.
About Atlas Biomed's Pitch Deck
Presented in 2018 for their Series B funding round, Atlas Biomed's pitch deck is a clear reflection of the company's mission to revolutionize personal health management. With a hefty $21.0 million secured from the round, the company exhibited the potential of its distinctive DNA and Microbiome Tests. The pitch deck emphasizes the value of these tests in gaining unique insights into disease risk profiles, metabolism of vitamins and micronutrients, and even genealogical roots.
Why Investors believed in Atlas Biomed?
Investors were likely allured to Atlas Biomed due to its commitment to advanced molecular technology and the novel proposition of personalized healthcare. The prominence given to its ISO 13485:2016 accreditation and privacy protection policies in the pitch deck also highlighted Atlas Biomed's commitment to professionalism and integrity. The company's unique approach to empowering individuals with control over their health, coupled with their potential to revolutionize healthcare, offered a compelling case for investment.
